AQST
Aquestive Therapeutics Inc
4.60$
+2.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18.1% | -37.4% | -86.2% | -34.9% | -87.7% | -54.7% | -268.3% | -79.1% | -98.8% | -65.1% | -102.5% | -68.3% | -83.9% | |
| 2.0% | 3.5% | 1.7% | 1.0% | 1.2% | 1.2% | 1.6% | 1.4% | 1.1% | 1.0% | 0.8% | 1.0% | 1.0% | |
| 6.0% | 7.1% | 13.1% | 7.7% | 11.6% | 20.2% | 18.2% | 18.8% | 21.7% | 10.6% | 16.0% | 20.9% | 17.3% | |
| -11.1% | -8.3% | -17.0% | -41.6% | -35.7% | 44.5% | -57.2% | 9.2% | -22.5% | 147.0% | -85.8% | -22.4% | 1.4% | |
| 1.2% | 0.1% | 0.2% | 0.2% | 0.6% | 0.1% | 1.5% | 1.1% | 1.8% | 0.7% | 0.4% | 1.5% | 1.1% | |
| -1.2% | -0.1% | -0.2% | -0.2% | -0.6% | -0.1% | -1.5% | -1.1% | -1.8% | -0.7% | -0.4% | -1.5% | -1.1% | |
| – | 0.1% | -7.4% | 0.0% | 6.6% | – | – | – | – | – | – | – | – | |
| – | – | – | – | -0.1% | 0.0% | -0.1% | -0.1% | -0.1% | 0.0% | -0.1% | 39.4% | 10.0% | |
| 38.3% | 29.6% | 678.2% | 8.5% | -0.1% | 1.3% | 236.8% | -1.0% | 635.7% | 5.1% | 30.6% | -18.7% | 155.1% | |
| 19.1% | -7.9% | 591.8% | -26.5% | -88.4% | -53.5% | -33.1% | -81.2% | 535.1% | -60.7% | -72.2% | -88.6% | 70.2% | |
| -19.2% | -37.5% | -86.4% | -35.0% | -88.3% | -54.8% | -269.9% | -80.2% | -100.6% | -65.7% | -102.9% | -69.9% | -85.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.